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Ablation: Who, When, and How?
Chin-Yu Lin
Abstract
In the past decades, it has been known that reentry circuits for ventricular tachy-
cardia or focal triggers of premature ventricular complexes are not limited to the 
subendocardial myocardium. Rather, intramural or subepicardial substrates may 
also give rise to ventricular tachycardia, particularly in those with non-ischemic 
cardiomyopathy. Besides, some of the idiopathic ventricular tachycardia might be 
originated from epicardial foci. Percutaneous epicardial mapping and ablation have 
been successfully introduced to treat this sub-epicardiac ventricular tachycardia. 
Herein, this chapter reviews the indications for epicardial ablation and the identi-
fication of epicardial ventricular tachycardia by disease entity, electrocardiography 
and imaging modalities. This chapter also described the optimal technique for 
epicardial access and the potential complication.
Keywords: epicardial, ventricular tachycardia, ablation, non-ischemic cardiomyopathy, 
idiopathic
1. Introduction
The pericardium is a two-layer membrane surrounding the heart and vital 
vessels. The two-layer structure included a serous visceral membrane inside and 
a fibrous membrane (parietal pericardium) outside. The fibrous membrane is 
adhered to the diaphragm, posterior part of sternum by the tissue and ligament 
to fix the heart. The pericardium encloses the heart and pericardial fluid, which 
provides lubrication for the myocardium [1]. Pericardial puncture is a standard 
and useful therapeutic procedure for the treatment of diagnosis of tamponade or 
symptomatic pericardial effusion [1]. In 1996, Sosa et al. first described the use of 
pericardial puncture in an electrophysiological laboratory for epicardial ablation 
in ventricular arrhythmia, [2] the use of pericardial puncture to map and ablate 
ventricular arrhythmia started to expand in other diseases [3].
Before to the era of catheter ablation with epicardial approach, patients with 
ventricular tachycardia (VT) refractory to catheter ablation from the endocardium 
often required surgical approach. The technique became well-developed and skilled 
in high-volume center recently. Many centers reported the successful application of 
the epicedial ablation in a diverse range of cardiac arrhythmia. Therefore, the indi-
cation for the epicardial approach has extended. The potential indication included 
substrate/ idiopathic VTs, accessory pathways, and miscellaneous supraventricular 
tachycardias [4]. Since Sosa et al. first introduced the application of epicardial 
ablation for the ventricular arrhythmias (VAs) in Chagas disease, [2] the use of this 
technique through a percutaneous method has been applied to other diseases [3].
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In the patients with ischemic cardiomyopathy due to prior myocardial infarc-
tion (MI) and VT, the involved circuit mostly involved the inner part of the heart 
[5]. In the previous report, part of the ischemic VT circuit may involve areas 
within the subepicardial area [6]. The advantage of the epicardial approach was 
demonstrated by clinical study. An approach with combined endo-epicardial 
mapping/ablation has been reported to show a better outcome selected 
patients with non-ischemic cardiomyopathy (NICM) VT ischemic VT [7–10]. 
Furthermore, the percutaneous technique for epicardial access have been proven 
to improve outcomes with an acceptable risk of peri-operative adverse event in 
experienced operator or high-volume centers [11]. However, there were many 
surrounding epicardial vascular structures or nerves in the tract of epicardial 
puncture. The unskilled operators may encounter serious and detrimental com-
plications. Prior studies have reported the incidence rate of major complications 
around 4.1-8.8%, including adverse event of a hemopericardium, intra-abdominal 
bleeding, and arterial/venous/nerve injuries [11–14]. This chapter was aimed to 
discuss the clinical implication, patient selection, and detailed procedure for the 
epicardial ablation in the patients with VA.
2. Who should be considered to perform the epicardial approach?
2.1 Contraindication for endocardial approach
Generally, the endocardial approach was contraindicated in the following 
condition,“
1. Endocardial mural thrombus was presented.
2. Coexisted mechanical valves were presented in the mitral and aortic valve.”
In the patient with the presence of newly-identified mural thrombus, the 
strategy of endocardial ablation should be postponed. Previous report described 
the results of endocardial VT ablation in 8 patients with identified old thrombus 
[15]. Intracardiac echocardiography (ICE) seems to be more sensitive for the 
detection of LV thrombi compared to transthoracic echocardiography (TTE) 
and is helpful in real-time navigation of the mapping / ablation catheter. No 
procedural or periprocedural complications were observed in this retrospective 
study [15].
Mechanical prosthetic aortic and mitral valves preclude either a retrograde 
aortic or transseptal approach to the left ventricle (LV) endocardium. Several 
operators have reported previously on the use of unconventional techniques during 
VT ablation such as transventricular septal puncture, [16, 17] epicardial approach, 
[18] transmechanical valve approach, [19] transcoronary venous approach, [20] or 
transapical approach [21].
2.2 Contraindication for percutaneous epicardial approach
Intrapericardial access is usually obtained through a subxiphoidal pericardial 
puncture. This approach might not be possible in patients with pericardial adhe-
sions caused by prior cardiac surgery, pericarditis, or prior epicardial ablation. 
(Figures 1 and 2) In such cases, a hybrid procedure involving surgical access to 
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a subxiphoid pericardial window or lateral thoracotomy might be a feasible and 
safe method of performing epicardial catheter ablation in the electrophysiology 
 laboratory [4].
Figure 1. 
Epicardial puncture in a patient with prior epicardial ablation. The figure showed the anterior–posterior 
view during epicardial puncture. The fluoroscopic view demonstrated the contrast stasis in the bottom of the 
epicardium due to prior ablation and severe adhesion. The wire could not advance further in the localized 
epicardial space.
Figure 2. 
Epicardial puncture in a patient with prior coronary artery bypass grafting. The figure showed the anterior–
posterior view during after an initial puncture. The fluoroscopic view demonstrated the contrast stasis in the 
bottom of the epicardium due to prior cardiac surgery severe adhesion. The wire could not advance further 
in the localized epicardial space (panel a). After several attempts, the ablation catheter was advanced to the 
limited epicardial space. Coronary angiography was done before the ablation to avoid coronary injury through 
the graft. (panel B).
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2.3 Endocardial approaches were more favorable than epicardial approach
2.3.1 Myocardial infarction related VT
The previous study showed a good response with subendocardial resection to 
treat the subendocardial location of the VT substrate from surgical experience, 
which indicated the endocardial VT circuits [22]. Furthermore, the endocardial 
catheter ablation with mappable VT demonstrated good acute procedural suc-
cess rate. However, the long-term outcome was unsatisfied [23]. A prior study 
examined all ischemic cardiomyopathy (ICM) VT cases with endocardial and/or 
epicardial mapping/ablation. Epicardial approach was applied in 14% of patients, 
and application of ablation in the epicardium was done in 8.5% patients. Part of 
the patient (0.5%) did not undergo epicardial ablation because of proximity to 
an epicardial coronary artery to the of identifying epicardial substrate [24]. In 
an Asian study from Taiwan, the epicardial approach for the ICM-related VT was 
rarely reported [14]. This may be related to the highest quality and convenience of 
Taiwan’s public health system. A recent non-randomized study provided evidence 
of epicardial-endocardial approach in these patients [25]. Generally, the region of 
myocardial infarction does not appear to be predictive of epicardial involvement. 
On the other hand, imaging, such as cardiac magnetic resonance imaging (MRI), 
cardiac computed tomography, or nuclear scintigraphy suggesting transmural 
infarction may identify patients more likely to have epicardial substrate [26].
2.3.2 Idiopathic ventricular arrhythmia
The recent review article summarized most common idiopathic VT arising 
from the right and left ventricle: (1) outflow tract VT, (2) fascicular VT, (3) intra-
cavitary VT, (4) perivalvular VT, and (5) epicardial VT [27]. Around 1. 8–9. 2% 
of idiopathic VT were raised from the epicardium. In the prior study, the electro-
cardiography is a useful parameter for predicting the successful ablation sites of 
VT originating from the continuum between the aortic sinus of Valsalva (ASV) 
and the left ventricle (LV) summit [28]. In the results, aVL/aVR Q-wave ratio is 
useful in the prediction of successful ablation sites. A coronary venous approach / 
pericardial access might be required with a cutoff value of 1.536-1.740 and > 1.740 
respectively.
2.4 Epicardial approaches were more favorable than endocardial approach
2.4.1 Brugada syndrome catheter ablation
Brugada syndrome (BrS) is one of the main causes of sudden cardiac arrest in 
young population [29]. The efficacy and adverse effects of anti-arrhythmic drugs on 
BrS was disappointing. Catheter ablation emerged and offers an alternative thera-
peutic strategy for these patients with repeat recurrent implantable cardioverter 
defibrillator (ICD) shock after the ICD implantation. Nademanee et al. first dem-
onstrated the effectiveness and safety of ablating the arrhythmogenic electrogram 
at the epicardium of right ventricular outflow tract (RVOT) to decrease the VT/
VF burden [30]. Further study on the post-mortem heart demonstrated interstitial 
fibrosis and reduced gap junction expression in the epicardium of RVOT in BrS 
patients. The abnormal fibrosis resulted in arrhythmogenic potentials. Eliminating 
the arrhythmogenic potentials by using ablation could abolish the BrS ECG pat-
tern and reduce VT/VF burden. In the clinical practice, the operator may perform 
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epicardial mapping and identified the slow conduction zone and abnormal elec-
trogram in the RV epicardially. (Figure 3) The electrophysiological group in Taipei 
Veterans General Hospital first introduced the warm water instillation, which would 
enhance the phenotype and functional substrate in the patient with BrS. Ablation 
by targeting the triggers and abnormal epicardial substrates provided an effective 
strategy for preventing ventricular tachyarrhythmia recurrences in BrS [31].
2.4.2 Arrhythmogenic right ventricular cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable desmo-
some disorder. The clinical manifestations vary from asymptomatic concealed stage, 
electrical abnormality with ventricular arrhythmias (VAs), to progressive heart 
failure [32, 33]. Catheter ablation is emerging as an alternative therapy for drug-
refractory VAs in patients with ARVC. Although the catheter ablation could result 
in acute procedural success with VT termination, the high incidence of recurrence 
limited the role of ablation in ARVC initially [34, 35]. The application of epicardial 
and endocardial ablation of VT in the patients with ARVC had been proposed with 
good effects acute and long-term outcome and VAs-freedom [36, 37]. Recent studies 
also demonstrated that 45 ~ 84. 6% patients were free from VA recurrences or ICD 
therapy through the combination of endocardial and epicardial ablation [38, 39]. 
Epicardial approach is required in more than one third ARVC patients for achieving 
non-inducibility in the prior reports [40]. The number of fulfilled SAECG criteria 
was correlated to the extent of diseased epicardial substrate and could be a potential 
surrogate marker to predict the requirement of epicardial ablation in ARVC with 
drug-refractory VA [40].
Figure 3. 
Local fractioned potential in the epicardial right ventricular outflow tract of a patient with Brugada 
syndrome. The left panel demonstrated local abnormal signal and delayed electrogram, which was localized in 
the epicardial right ventricular outflow tract. (red arrow, right panel) this patient was diagnosed as Brugada 




In contrast to ischemic cardiomyopathy, non-ischemic cardiomyopathy (NICM) 
consists of a heterogeneous group of diseases [41] affecting the myocardium. 
Despite the progress and improvement in the pharmacological medication of heart 
failure in recent decades have significantly decreased the disease progression and 
mortality in NICM patients, anti-arrhythmic medications and ICD implantations 
remain the most important treatment for patients carrying a high risk of VT/VF or 
who have experienced aborted SCD due to fatal VT/VF [42]. Owing to the improve-
ment in electro-anatomic mapping and ablation catheter, catheter ablation of VT in 
NICM patients has been recognized as an upcoming issue [43]. A prior study proven 
the promising results that a successful catheter ablation could reduce VT recur-
rences and improve the survival in NICM patients regardless of the functional class 
status or left ventricular function [44]. NICM VTs in different disease entities could 
result from non-uniform arrhythmogenic substrates, which can lead to different 
ablation outcomes.
With the exception of ARVC and BrS, the arrhythmogenic substrates in NICM 
that could be identified by electroanatomic mapping, are mostly located in the 
base or perivalvular region of the LV, which is distinct from the substrate ICM 
[45]. The arrhythmogenic potentials could be identified from the endocardial/epi-
cardial aspect in the patients with NICM [46]. These arrhythmogenic substrates 
frequently associate fibrosis tissue that leads to conduction disturbance and frac-
tionated electrograms [47]. Aside from the electroanatomic substrate mapping 
with bipolar/unipolar voltage, cardiac MR can provide additional information 
to unmask the scar distribution as a non-invasive manner [48–50]. Additionally, 
patients with scar involving the inferolateral aspect of the LV, which frequently 
requires an epicardial approach, usually have a better prognosis than those with 
anteroseptal scar [51].
A comprehensive investigation of patients with NICM and VT includes cardiac 
imaging and genetic testing. These information might enable recognition of undiag-
nosed diseases, such as isolated and active cardiac sarcoidosis or inherited cardio-
myopathies. An accurate diagnosis could improve patient selection for ablation and 
early consideration of individualized treatments [52].
3. When should be considered to perform the epicardial approach?
An epicardial approach could performed for patients with refractory ablation 
from an endocardial approach. The clinical documentation of surface ECG could 
provide specific electrocardiographies evidence supporting an epicardial origin 
[28, 53, 54]. In cases with a disease entity favoring an epicardial substrate, or those 
with electroanatomic mapping supporting the existence of a diseased epicardial 
substrate, an epicardial approach could be considered [30, 55, 56].
Before preparing for epicardial approach, the first step is to localize the VT origin 
and identify the potential regions of arrhythmogenic substrates. The surface ECG 
morphologies provide the information about the origin and the potential need for 
an epicardial approach [53]. Standardized echocardiography or intracardiac could 
delineate the valvular structure, area of hypokinesia or akinesia, and excluding any 
intracardiac thrombus [57]. Computed tomography (CT) and cardiac MRI with a 
late gadolinium enhancement, could localize the regions of abnormal tissue in spe-
cific protocol [48–50]. The distribution and extent of the scar is useful for deciding 
the ablation strategy, such as an epicardial approach, transcoronary venous ablation, 
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alcohol ablation, or simultaneous bipolar ablation. The integration of the recon-
structed images obtained from CT and MRI and 3-D navigation, mapping systems 
(Figure 4) can aid in the illustration of the structural complexity and avoidance of 
damage to the critical regions, in terms of vascular or nervous structures.
4. How to perform the epicardial approach?
4.1 Traditional method (posterior approach)
After obtaining informed consent, the procedure would be performed with 
the patients in a fasting state under general anesthesia. Pre-procedure subxiphoid 
echocardiography was recommended to perform routinely. In some cases, the echo-
cardiography could help the operator avoid liver or gastric injuries. A subxiphoid 
puncture was performed to penetrate the pericardium in the inferior aspect of 
the hear according to the technique described by Sosa et al [2]. Access to the peri-
cardium was achieved by using an 18 G Tuohy Needle (Arrow International, Inc., 
Reading, PA, USA) in the laboratory of Taipei Veterans General Hospital through 
the subxiphoid process. The anteroposterior projection was usually used to direct 
the access in the anterior/posterior plane, while the left anterior oblique (LAO) 60° 
projection was used to guide the needle leftward tangentially to the cardiac border. 
Figure 5 demonstrated the adjacent structure with these two views by reconstruc-
tion of the CT. After passing through the diaphragm, 1-2 cm3 of contrast could be 
injected between the diaphragm and pericardium to observe tenting of the pericar-
dium. After entering the posterior side of pericardium, a 0.032 guidewire would 
be advanced to the left heart border in the LAO projection, and 10 cm3 of contrast 
could be injected into the pericardial space through a 5F dilator or the side hole of 
a 5Fr sheath to allow for visualization of any adhesions. (Figure 6) An 8-Fr Sheath 
or flexible long Sheath would be exchanged by using the guide wire. The ablation/
mapping catheter would be inserted through the sheath after obtain the access to 
avoid injury by the edge of the sheath. Angiography would be performed while 
locating the catheter in the interested area to avoid coronary injury. (Figure 7) After 
the procedure, the epicardial sheath was exchanged for a pigtail. Pericardial injec-
tions of hydrocortisone 100 mg and ketorolac tromethamine 30 mg were routinely 
given immediately and 24 hours after the epicardial procedure to prevent any future 
epicardial adhesions or pericarditis.
Figure 4. 
Cardiac magnetic resonance imaging (CMRI) and three-dimensional reconstruction in a patient with non-
ischemic myocardial infarction. The CMRI demonstrated a late gadolinium enhancement (LGE) in the mid 




A ‘needle-in-needle’ technique for epicardial access has been described by 
Kumar et al [58]. In this approach, a 7-cm 18-gauge needle is inserted beneath the 
sternum. The purpose of this short needle is to provide stability and tactile feedback 
for a long (15- or 20-cm) micropuncture 21-gauge needle, which is inserted through 
the 18-gauge needle. Once the 21-gauge needle is inserted into the pericardial space, 
along 0.018-inch guidewire with a floppy tip is advanced into the pericardial space. 
Upon fluoroscopic confirmation that the guide wire has been inserted into the 
pericardium both needles are then removed. Micropuncture dilators are then used 
to upsize the guide wire to a 0.35-inch wire and ultimately, an 8-Fr sheath is intro-
duced into the pericardial space. The ‘needle-in-needle’ approach was compared to 
the traditional methods. Successful epicardial access was achieved in 100% of the 
‘needle-in-needle’ cases, as compared to 94% with the Sosa technique. Failure of 
epicardial access in the traditional method were due to prior cardiac surgery [13] or 
Figure 6. 
Epicardial puncture in a patient with arrhythmogenic right ventricular cardiomyopathy. The anterior–
posterior view (left panel) and LAO view (right panel) showed the wire in the epicardial space surrounding 
the whole heart and the contrast in the epicardial space without adhesion.
Figure 5. 
The anatomy with anterior–posterior view (left panel) and LAO view (right panel). The green arrow 
indicated the anterior approach and the red arrow indicated the posterior approach.
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adhesions from prior epicardial mapping/ablation or episodes of pericarditis [7]. 
Major pericardial bleeding was similar between both techniques [58].
4.3 Anterior approach vs. posterior approach
In anatomic, there is a potential space below the sternum and xyphoid process. 
While puncturing below the xyphoid process, the needle might directly pass 
through the fibrous pericardium avoiding the puncture through the diaphragm 
[59]. The term of “anterior approach” was used for the epicardial approach via this 
potential space. (Figure 8) This approach was based on the previous finding that 
an increased fluid in the anterior part of the heart during supine position [60, 61]. 
Theoretically, the density of myocardium is heavier than and pericardial fluid. 
During supine position, the heart might force the pericardial fluid to the anterior 
part within the pericardium. Keramati et al. reported the anterior approach was 
successfully performed in 100% of patients in their study cohort [62]. The success 
rate was similar between the anterior approach and the needle in needle approach. 
On the other hand, the success rate of the anterior approach was higher than the 
traditional approach. In the report, there were no major pericardial hemorrhage 
and even the PV puncture. Figure 9 demonstrated the illustration of the anterior 
approach and posterior approach.
4.4 Fluoroscopic approach with carbon dioxide insufflation
The technique of carbon dioxide insufflation was first reported with right atrial 
exit in human study by Greenbaum et al [63]. A modified approach with exit from 
the coronary sinus was reported by Silberbauer et al [64]. The pericardial space was 
insufflated with carbon dioxide after creating the exit, which allowing visualiza-
tion of the pericardial membrane and separated membrane to the myocardium. 
The epicardial space with carbon dioxide allowed safe epicardial puncture and 
minimized the risk of RV perforation. A multi-center registry was conducted with 
Figure 7. 
Angiography before epicardial ablation. After a successful epicardial puncture through posterior approach, the 
angiography was performed before the ablation to avoid coronary injury.
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this modified approach. There was no patient complicated with the RV puncture of 
coronary artery injury [65]. However, the operator needs to take care of the poten-
tial risk of bleeding from the exit site.
4.5 Wire-guided puncture
This approach was first described by Long et al [64] in 2019. This approach was 
different from traditional approach using the contrast-filled syringe to the needle. 
Figure 8. 
An illustration of anterior and posterior approach. The figure showed the X-ray from the lateral view. 
The green arrow indicated the anterior approach and the red arrow indicated the posterior approach. The 
horizontal cut of the hears from lower caudal part of the cranial part. The white arrow indicates the sequence 
from the lower part of the higher part. Each cut was corresponding to the horizontal while line in the X-ray.
Figure 9. 
Example of anterior approach. Anterior approach was performed successfully. The guide wire was exchanged 
with an 8 Fr sheath after confirming the location.
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In the wire-guided approach, a J-tipped guide wire is within the needle during 
puncture. After advancing the needle the adjacent area of the pericardium, the wire 
was advanced. The wire would curve back if it reached the parietal pericardium, 
and the operator could feel the heart pulsations. The wire was dragged back to the 
needle’s tip at this point. The wire and needle were both pressed again at the same 
time. While the needle was traveling through the epicardium, the wire would fall 
into the pericardial region. The study found that this method was safe and that the 
success rate was comparable to that of the traditional method.
4.6 Surgical access
Pericardial window provides clear visualization of the epicardial myocardium 
and manipulation of the mapping catheter and Realtime feedback for the location 
of the mapping catheter cooperating with the 3-D anatomic mapping system. The 
operator might not able to perform percutaneous subxiphoid access in patients with 
pericardial adhesions. In these patients, a surgical window may be required to gain 
access to the pericardium. This technique involves a subxiphoid incision, followed 
by manual lysis of adhesions to visualize the epicardial surface. A sheath was then 
placed into the pericardial space after opening a small window in the pericardium 
[66]. This technique should be considered in patients with a prior history of cardiac 
surgery with dense pericardial adhesions [67].
5. Periprocedural complications of an epicardial approach
In the prior report, the incidence of major complications was 10.0%, and that 
for minor complications was 17.5% [14]. Prior single and multicenter studies also 
reported similar findings [11, 12]. However, it is important to keep in mind that 
these complication rates were obtained from arrhythmia centers with an experi-
ence of epicardial approach. The surgical backup was required for potential major 
complications. Major complications of intra-abdominal bleeding due to vessel 
damage and MI owing to ablation in the adjacent area were reported [68]. Another 
possible cause of intra-abdominal bleeding is the liver puncture or perforation. The 
operator should also take care for the location of the coronary sinus. Coronary sinus 
puncture might occur if the puncture site is close to the base of the heart. Thus, 
detailed preoperative evaluations by ECG, echocardiography, and peri-operative 
image, especially for patients with hepatomegaly or a congested liver, may prevent 
the occurrence of any life-threatening complications.
RV puncture was not uncommon and it has been reported to be a minor com-
plication with an incidence of 4. 5 ~ 7. 5% [13, 14, 68]. The RV puncture could 
be reduced after a learning curve. Post-procedural pericarditis was common. 
Prolonged and intolerable chest pain due to pericarditis might be improved by the 
administration of intrapericardial steroids and non-steroidal anti-inflammatory 
drugs. Phrenic nerve injuries and coronary artery damage could be avoided by 
phrenic nerve pacing and pre-ablation angiography [69, 70].
5.1 Patients with anticoagulant
In the patient with anticoagulant, the epicardial access could be performed 
according to the guideline. After excluding the potential risk of adhesion, history 
of epicardial surgery, and complex anatomy, the procedure might be classified as 
a minor risk procedure in an experienced operator [71]. Therefore, the procedure 
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and resume after the procedure or latest next day without active bleeding. Beside, 
the procedure should be better performed by experienced operator and avoid 
repeated RV puncture. Antidote or blood transfusion should be available in the 
hospital.
6. Conclusion
The need for an epicardial approach for VA ablation displayed a gradually 
increasing trend. The disease entity, prior surgery or ablation, electrocardiography, 
image study, and other diagnostic test should be carefully reviewed before the deci-
sion making. The prior studies demonstrate the effectiveness of epicardial catheter 
ablation with acceptable safety in experienced referral center.
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